Jubilant Biosys Limited
Anil Srivastava has over two decades of work experience in the pharmaceutical and bioscience industries. Anil began their career at Procter & Gamble Pharmaceuticals as an Overseas Researcher and then worked at Chembiotek Research International as a Team Leader. In 2006, they joined Jubilant Chemsys Ltd. as a Group Leader before progressing to roles such as Principal Scientist, Senior Principal Scientist, and Assistant Director. Anil then became an Associate Director at Jubilant Chemsys Ltd. and later served as Director at Jubilant Chemsys Limited, which merged with Jubilant Biosys Ltd. in 2020. Currently, they hold the position of Associate Vice President at Jubilant Biosys Limited.
Anil Srivastava earned a Doctor of Philosophy (Ph.D.) degree in Medicinal and Pharmaceutical Chemistry from the Central Institute of Medicinal and Aromatic Plants (CIMAP), Lucknow, India, from 1996 to 2000. Prior to that, they completed a Master of Science (M.Sc.) degree in Organic Chemistry from the University of Lucknow between 1993 and 1995.
This person is not in the org chart
Jubilant Biosys Limited
1 followers
Jubilant Biosys Ltd (JBL) offers end-to-end CRDMO solutions in Structural Biology, Computational Chemistry, Medicinal & Synthetic Chemistry, in-vitro and in-vivo Biology, DMPK, Toxicology, Process R&D & Manufacturing to various Biotech & Pharma companies pursuing drug discovery, development and manufacturing. Jubilant Biosys Limited (JBL) is a subsidiary of Jubilant Pharmova, serving the global life sciences, agrochemicals and specialty chemicals industry through its research centers & manufacturing facilities in India. Jubilant’s services in discovery research include; Jubilant’s services in discovery research includes; • Target Identification/Target Validation to Lead Optimization/ Preclinical candidate, for multiple therapeutic areas viz; Oncology, Metabolic Disorders, CNS, Pain and Inflammation. • Functional services comprising of computational chemistry/ molecular modeling, medicinal chemistry, synthetic chemistry, scale-up (Non-GMP & GMP), structural biology, ADME-PK,in-vitro and in-vivo biology and IND enabling GLP toxicology.